Complicated UTI an economic obstacle for healthcare systems Newsletter Article 17 February 2013 Pages: 2 - 2
Demand for quality-of-life studies is increasing Tracey Langsdale Newsletter Article 17 February 2013 Pages: 3 - 4
Physicians working under capitation - do they act like health insurers? Newsletter Article 17 February 2013 Pages: 6 - 6
Azithromycin or doxycycline for chlamydial infections? Newsletter Article 17 February 2013 Pages: 7 - 7
Warfarin underused in stroke prevention - US outcomes data Newsletter Article 17 February 2013 Pages: 7 - 7
ATG vs muromonab-CD3 for induction therapy in renal transplant Newsletter Article 17 February 2013 Pages: 9 - 9
Economics of first-ever stroke - the Dutch perspective Newsletter Article 17 February 2013 Pages: 10 - 10
Patient involvement improves care for prostate disease Newsletter Article 17 February 2013 Pages: 10 - 10
Propofol induction anaesthesia provides cost advantage Newsletter Article 17 February 2013 Pages: 11 - 11
PBSC transplantation + filgrastim improve health outcomes Newsletter Article 17 February 2013 Pages: 12 - 12
Best supportive care valued by patients with NSCLC Newsletter Article 17 February 2013 Pages: 13 - 13
Brief QOL scale ‘cost-effective’ in the oncology setting Newsletter Article 17 February 2013 Pages: 13 - 14
Guidelines must deliver economies or else, warns French Minister Newsletter Article 17 February 2013 Pages: 14 - 14
Drug marketing and information transfer in managed care Newsletter Article 17 February 2013 Pages: 15 - 15